ncRNA name
LncRNA 005620
Specific or universal ncRNAs
Specific ncRNAs
Class
Long noncoding RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
ITGB1
Cancer name
Triple-Negative Breast Cancer
Cancer site
qRT-PCR,Western blot
Treatment type
Chemotherapy
Drug
Epirubicin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Novel Long Noncoding RNA 005620 Induces Epirubicin Resistance in Triple-Negative Breast Cancer by Regulating ITGB1 Expression
Tissue resource
primary cancer tissue and adjacent nonācancerous tissue samples
human triple-negative breast cancer cell lines MDA-MB-231
Experiment
None
Institute
the Affiliated Obstetrics and Gynaecology Hospital of Nanjing Medical University
Chinese Type Culture Collection, Chinese Academy of Sciences
Country
China
China
Continent
Asia
Asia